Risk Analysis Strategy
  • Stock
  • Business
  • Politics
  • Investing
Business

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

by admin April 30, 2025
April 30, 2025

Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development. 

Bourla’s remarks on the company’s first-quarter earnings call came in response to a question about what Pfizer wants to see from tariff negotiations that would push the company to increase investments in the U.S. It comes as drugmakers brace for Trump’s levies on pharmaceuticals imported into the country — his administration’s bid to boost domestic manufacturing.

“If I know that there will not be tariffs … then there are tremendous investments that can happen in this country, both in R&D and manufacturing,” Bourla said on the call, adding that the company is also hoping for “certainty.”

“In periods of uncertainty, everybody is controlling their cost as we are doing, and then is very frugal with their investment, as we are doing, so that we are prepared for remit. So that’s what I want to see,” Bourla said.

Bourla noted the tax environment, which had previously pushed manufacturing abroad, has “significantly changed now” with the establishment of a global minimum tax of around 15%. He said that shift hasn’t necessarily made the U.S. more attractive, saying “it’s not as good” to invest here without additional incentives or clarity around tariffs.

“Now [Trump] I’m sure — and I know because I talked to him — that he would like to see even a reduction in the current tax regime particularly for locally produced goods,” Bourla said, adding a further decrease would be would be a strong incentive for manufacturing in the U.S.

Unlike other companies grappling with evolving trade policy, Pfizer did not revise its full-year outlook on Tuesday. However, the company noted in its earnings release that the guidance “does not currently include any potential impact related to future tariffs and trade policy changes, which we are unable to predict at this time.”

But on the earnings call on Tuesday, Pfizer executives said the guidance does reflect $150 million in costs from Trump’s existing tariffs.

“Included in our guidance that we didn’t really speak about is there are some tariffs in place today,” Pfizer CFO Dave Denton said on the call.

“We are contemplating that within our guidance range and we continue to again trend to the top end of our guidance range even with those costs to be incurred this year,” he said.

This post appeared first on NBC NEWS

previous post
JetBlue to partner with another U.S. airline in the coming weeks
next post
Empire Metals: Advancing a Game-changing, Globally Significant Titanium Project in Western Australia

Related Posts

5 new Uber features you should know —...

May 15, 2025

Microsoft to cut 3% of its workforce

May 14, 2025

Fintech company Chime files for Nasdaq IPO

May 14, 2025

Fox streaming service to be called Fox One,...

May 13, 2025

Walgreens doubles down on prescription-filling robots to cut...

May 13, 2025

Cava revenue beats estimates as Mediterranean chain reports...

May 17, 2025

Boeing would avoid guilty plea, prosecution over 737...

May 17, 2025

‘Shark Tank’ alum Bombas taps former Under Armour...

May 16, 2025

Reddit co-founder Alexis Ohanian takes minority stake in...

May 16, 2025

YouTube will stream NFL Week 1 game in...

May 15, 2025

5 new Uber features you should know —...

May 15, 2025

Microsoft to cut 3% of its workforce

May 14, 2025

Fintech company Chime files for Nasdaq IPO

May 14, 2025

Fox streaming service to be called Fox One,...

May 13, 2025

Walgreens doubles down on prescription-filling robots to cut...

May 13, 2025

Cava revenue beats estimates as Mediterranean chain reports...

May 17, 2025

Boeing would avoid guilty plea, prosecution over 737...

May 17, 2025

‘Shark Tank’ alum Bombas taps former Under Armour...

May 16, 2025

Reddit co-founder Alexis Ohanian takes minority stake in...

May 16, 2025

YouTube will stream NFL Week 1 game in...

May 15, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Stock News

    • The Best Five Sectors, #19

      May 19, 2025
    • Emerging Stocks to Watch – Breakouts, Momentum & Upgrades!

      May 19, 2025
    • S&P 500 Now in Weakest Seasonal Period…Or Is It?

      May 18, 2025
    • Emerging Stocks to Watch – Breakouts, Momentum & Upgrades!

      May 18, 2025
    • S&P 500 Now in Weakest Seasonal Period…Or Is It?

      May 17, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions


    Copyright © 2025 RiskAnalysisStrategy.com All Rights Reserved.

    Risk Analysis Strategy
    • Stock
    • Business
    • Politics
    • Investing